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Summary A number of reports indicate that protein synthesis is a requirement for the occurrence of
apoptosis. In this study, the effect of the protein synthesis inhibitor cycloheximide (CHM) on spontaneous
apoptosis of B-chronic lymphocytic leukaemia (B-CLL) cells, previously shown to occur when they are
cultured in RPMI-1640 medium with autologous or heterologous serum, was examined. No definite inhibition
of apoptosis was observed. Indeed, CHM-treatment augmented apoptosis in the B-CLL cultures and also
induced apoptosis of cultured normal peripheral blood lymphocytes. Augmentation was dose-dependent for
B-CLL cells over the concentration range 106 M (0.28 yigml-') to 102 M (2800 ygml-'), resulting in 9% to
98% apoptosis respectively by 24 h of culture (r = 0.619, P = 0.0008). Normal lymphocytes were affected by
CHM over the range 10-4 M to 10-2 M, resulting in 7% to 74% apoptosis respectively (r = 0.794, P = 0.0001).
Inhibition of protein synthesis in these cells by CHM was virtually complete at a concentration of 10-3 M. The
findings are in accord with some recent reports indicating that suppression of protein synthesis by CHM does
not inhibit apoptosis in all circumstances. They also illustrate the marked susceptibility of B-CLL cells,
compared with normal lymphocytes, to the induction of apoptosis by this drug. The manner in which CHM
triggers apoptosis of some cell types is at present uncertain.
Cell death takes two distinct forms, necrosis and apoptosis,
which differ in morphology, biochemistry, incidence and
biological significance (reviewed by Wyllie et al., 1980 and
Walker et al., 1988). Whilst necrosis is an outcome of severe
injury, apoptosis frequently appears to have a homeostatic or
adaptive function (Kerr et al., 1972). Much recent research
on apoptosis has been directed towards elucidating its bio-
chemical mechanisms (reviewed in Kerr & Harmon, 1991).
Apoptosis occurring in a number of circumstances has
been reported to be abrogated by inhibitors of macro-molec-
ular synthesis such as cycloheximide (CHM), actinomycin D
(Act D), puromycin and emetine (Cohen & Duke, 1984;
Wyllie et al., 1984; Yamada & Ohyama, 1988). Specifically,
these circumstances include irradiation of gut crypts (Lieber-
man et al., 1970) and thymocytes (Sellins & Cohen, 1987;
Yamada & Ohyama, 1988); exposure ofbone marrow cells to
cancer-chemotherapeutic agents (Ben-Ishay & Farber, 1975);
dioxin treatment of thymocytes (McConkey et al., 1988);
glucocorticoid treatment of B-chronic lymphocytic leukaemia
(B-CLL) cells (Galili et al., 1982), thymocytes and lymphoid
cell lines (Cohen & Duke, 1984; Wyllie et al., 1984); regres-
sion of the tadpole tail induced by thyroxine (Tata, 1966);
fusion of the palatal shelf epithelium during normal develop-
ment (Pratt & Greene, 1976); and withdrawal of IL-2 from
T-lymphocytes (Bishop et al., 1985) or of fibroblast growth
factor from endothelial cells (Araki et al., 1990).
Suppression of apoptosis by inhibitors of RNA and/or
protein synthesis does not, however, appear to be universal.
Systems in which an inhibitory effect has been reported to be
absent include apoptosis of target cells induced by cytotoxic
T lymphocytes (Duke et al., 1983), apoptosis of activated T
cells and macrophages induced by the fungal metabolite
gliotoxin (Waring, 1990), apoptosis of human promyelocytic
leukaemia HL-60 cells incuded by calcium ionophore or
microtubule-disrupting agents (Martin et al., 1990), and
apoptosis induced in human and murine cell lines by mild
hyperthermia (Takano et al., 1991).
We have previously shown that approximately 20% of
unstimulated B-CLL cells spontaneously undergo apoptosis
within 30 h when cultured in RPMI-1640 medium with either
autologous or heterologous serum (Collins et al., 1989). In
the present study we sought to determine the protein syn-
thetic requirements of the apoptosis in this model using the
frequently employed protein synthesis inhibitor CHM.
Materials and methods
Patient selection and cellpreparation
Peripheral blood was collected from eight patients diagnosed
as having B-CLL by standard clinical and haematological
criteria. Mononuclear cells (MNC) were isolated by differ-
ential centrifugation (Boyum, 1968) using Ficoll-Paque
(Pharmacia, Uppsala, Sweden) and adjusted to a concentra-
tion of 2 x 107ml-' in Hank's balanced salt solution (HBSS)
(Gibco, Ohio, USA). Normal peripheral blood MNC were
obtained from nine healthy laboratory personnel.
Phenotype analysis
Surface membrane antigens were demonstrated by an indirect
immunofluorescence technique using a variety of monoclonal
antibodies: OKT1 (CD2) (Ortho, NJ, USA); PCA-1, Bl
(CD20), B4 (CD19), J5 (CDIO) (Coulter, Fla., USA); Leu4
(CD3), Leu3a (CD4), Leu2a (CD8), LeuM3 (CD14), Leul
(CD5), Interleukin-2 Receptor (CD25), HLA-DR, HLe-l
(CD45) (Becton Dickinson, Calif. USA); FMC7 (Flinders
Medical Centre, Adelaide, Australia) and mouse IgG and
IgM as negative controls. Immunofluorescence was analysed
using an EPICS 741 flow cytometer (Coulter, Fla, USA) and
a result taken as positive when more than 15% of the
lymphocytes exhibited a fluorescence intensity greater than
the negative control. Surface membrane immunoglobulins
(SmIgs) were detected by a direct immunofluorescence techni-
que using FITC-conjugated F(ab)2 goat antihuman Ig (Kalle-
stad, Tex, USA) specific for heavy chains and light chains.
Mouse red blood cell (MRBC) receptors were detected by the
technique described by Zola (1977).
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Cell culture
MNC were incubated with increasing concentrations (10-' to
10-2 M) of CHM (Calbiochem, USA) in RPMI-1640 medium
containing 10% heat-inactivated autologous serum. The
CHM was initially dissolved in RPMI-1640 at a concentra-
tion of 5 x 102 M; this solution was sterilised with a 0.22 Am
filter immediately before dilution with RPMI-1640. Ten ml
aliquots of cell suspension, at a cell concentration of 2 x 106
ml-', were added to 25 cm2 culture flasks (Costar, USA) and
incubated at 37°C in an atmosphere of 5% CO2 in air.
Control and CHM-containing cultures were harvested at 24 h
and processed for microscopy as described below. The time-
course of the effects of CHM was assessed in cultures con-
taining 10-', 10-' and 10-3 M CHM harvested at 6, 16, 20
and 24 h; control cultures were also studied at these times.
Microscopy andquantification ofcell death
Cell death was identified and quantified by light microscopy,
the validity of the identification being confirmed by electron
microscopy. Cells were washed once in standard phosphate-
buffered saline and fixed for 1 h at 4°C in 3% glutaraldehyde
(Probing and Structure, Kirwan, Australia) in 0.1 M sodium
cacodylate buffer pH 7.3 (BDH Chemicals, Australia) con-
taining 1 M CaCl2 and 0.4 M sucrose. The cells were then
resuspended in 1 ml of buffer without glutaraldehyde, post-
fixed in 1% aqueous osmium tetroxide for 2 h, washed in
deionised water, stained en bloc in 5% aqueous uranyl ace-
tate, dehydrated through a series of graded ethanol solutions,
cleared in propylene oxide, and embedded in an epon/araldite
mixture. Sections cut on an LKB Ultratome V at 1 gim and
stained with 1% toluidine blue in 1% aqueous borax solution
were used for light microscopy and to select representative
areas for electron microscopy. Apoptosis and necrosis were
identified by light microscopy using previously defined
criteria (Walker et al., 1988). The majority of the cells
present were lymphocytes, most monocytes adhering to the
culture flasks. A minimum of 500 cells were examined to
determine the percentage of apoptosis present. Ultrathin sec-
tions were stained with lead citrate and the ultrastructural
features of dying cells examined using an Hitachi H-300
electron microscope.
DNA extraction and electrophoresis
MNC were lysed overnight at 37°C in 1 ml of a solution
containing 100 mM Tris HCI (pH 7.8), 1 mM EDTA, 10 mM
NaCl, 1% sodium dodecylsulphate and 1 mg ml1 of pro-
teinase K. The lysed cells were extracted in phenol and
digested in RNAase at 37°C for 45 min. The RNAase-treated
lysates were extracted once each in phenol/chloroform/iso-
amyl alcohol (25:24:1, v/v) and chloroform/isoamyl alcohol
(24:1, v/v). DNA was precipitated with 3 M sodium acetate
and ethanol and resuspended in 100pl TE buffer (10 mM Tris
pH 7.8, 1 mM EDTA). DNA (10 gg) was electrophoresed in
1.8% agarose gels containing ethidium bromide at a final
concentration of 0.5 lag ml-' for 12 h at 30 v. A HindIII
digest of lambda phage DNA (Bethesda Research Labora-
tories) served as the molecular weight marker. The gels were
photographed under UV light.
Measurement ofprotein synthesis using 35S methionine
To determine the inhibitory effect on protein synthesis in
normal lymphocytes of concentrations of CHM shown to
induce apoptosis, 2 x 105 cells were cultured in flat-bottomed
microtitre plates in 200 l.l of serum-free medium, either with-
out CHM or after addition of the drug at concentrations of
lo-,, 10- or 10- M.
The serum-free medium comprised 1:1 RPMI-1640 and
Iscove's modified Dulbecco's medium (Sigma, USA) contain-
ing 2 mg ml' bovine serum albumin, 20 tg ml1' soybean
lipid (Boeringher Mannhein, Germany), 20 Lgml1' transfer-
rin and 3 pg ml insulin (Sigma, USA). At the beginning of
the test period, all cultures were pulsed with 20pCi of L-35S
methionine (SJ.1515, Amersham, England) and incubated in
5% CO2 in air at 37°C. Cells were harvested (Dyntech,
Multimash 2000 cell harvester) at 5 min and at 2, 6, 21 and
24 h onto filter paper and washed with 200 ml cold HBSS;
protein was precipitated by washing with 200 ml of cold 5%
trichloroacetic acid. Incorporated 35S methionine was measur-
ed using Ready Safe scintillant (Beckman, CA, USA); sam-
ples were counted for 1 min on a Packard TRI-CARB
2000CA , counter and results expressed as counts min 1.
Statistical analysis
Pearson's correlation coefficient and Student t-test were per-
formed using the Complete Statistical System computer
package (StatSoft, OK, USA).
Results
Phenotype analysis
The phenotype of the patient's cells was typical of B-CLL,
the neoplastic cell population comprising monoclonal B-
lymphocytes, which were immunoglobulin light chain restrict-
ed and CDl9-, CD20-, CD5- and MRBC-positive (Table I).
Identification ofthe mode ofcell death
The light and electron microscopic features of virtually all of
the cell death present in both the control and CHM-treated
cultures were typical of apoptosis (Walker et al., 1988). The
characteristic condensation and compaction of nuclear chro-
matin to form circumscribed masses are illustrated in Figure
1. Only a very occasional necrotic cell was observed; the
frequency of necrosis was not influenced by CHM treatment
(data not shown).
Effect ofincreasing molarity ofcycloheximide
In untreated cultures from the eight patients with B-CLL, the
average level of spontaneous apoptosis at 24 h was 10%. No
significant diminution in this level of apoptosis was recorded
Table I Phenotypic profile of B-CLL patients
Pat Hb WBC LYMP CD2 CD3 CDI9 CD20 CD5 C7 Ia SmIg MR
1 10.2 146 146 5 4 55 94 95 1 94 MDK 49
2 11.1 160 154 8 8 83 87 98 0 98 MDK 58
3 11.9 19 19 11 5 81 90 95 20 95 MDL 78
4 12.9 44 35 11 11 75 89 97 1 88 MDK 91
5 10.9 172 167 4 3 77 94 98 2 94 MDK 90
6 12.6 63 63 2 2 80 96 98 1 98 MDL 62
7 13.5 43 32 11 16 70 74 90 3 98 MDK 80
8 11.9 20 15 18 15 70 72 92 0 96 MDL 74
Hb, Haemoglobin gdl-'; WBC, White cell count x I0 1-'; LYMPH, Lymphocyte
count x I091-'; CD2, OKTIl %; CD3, OKT3 %; CDl9, B4 %; CD20, BI %; CD5,
Leu-l %; C7, FMC-7 %; Ia, HLA-DR %; SmIg, Surface membrane immunoglobulin;
MR, Mouse red blood cell rosettes %.520 R.J. COLLINS et al.
Figure 1 Characteristic ultrastructure features of apoptosis in B-CLL cells cultured with 10-3 M cycloheximide for 24 h. Arrow
indicates a non-apoptotic B-CLL lymphocyte. Scale bar = 5 m.
for any of the concentrations of CHM studied. In fact, a
significant increase in the extent of apoptosis was recorded
for all concentrations of CHM> than 10-5M, with very
extensive apoptosis being observed at 10-3 M and 10-2 M
(Figure 2). A dose-dependent correlation existed between the
extent of apoptosis and the concentration of CHM over the
concentration range 10-6 to 10-2 M (r = 0.619, P = 0.0008).
Compared with the B-CLL cells, normal lymphocytes were
less severely affected, with a marked increase in apoptosis
occurring at only 10'- and 10-2 M CHM, a dose-dependent
correlation being apparent over the range 10-' to 10-2 M
(r = 0.794, P = 0.0001) (Figure 2). The level of spontaneous
apoptosis of normal lymphocytes never exceeded 5%
throughout the entire observation period.
Time-course ofthe response to cycloheximide
The time-course of the apoptotic response of B-CLL cells to
CHM varied with the concentration; representative data for
three patients using 10', 10' and 10- M CHM are shown
in Figure 3. With 10-3 M CHM, a significant increase in
apoptosis above the spontaneous levels was apparent by 6 h
of culture (P<0.05). With 10-5M CHM, 20h of culture
were required to produce an increase showing a similar level
of significance (P<0.025).
Electrophoretic analysis ofDNA
DNA isolated from B-CLL cells cultured for 24 h with con-
centrations of CHM ranging from 10-' to 10-2 M showed the
fragmentation pattern characteristic of apoptosis on electro-
phoresis (Figure 4) (Wyllie, 1980; Arends et al., 1990). A
comparison with molecular weight markers indicated that the
fragments were multiples of approximately 180-200 base
pairs, indicating cleavage of chromatin at the internucleo-
somal region.
DNA from cultures of B-CLL cells treated with the higher
concentrations of CHM showed a greater extent of DNA
fragmentation and a higher proportion of low molecular
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Figure 2 Apoptosis induced by increasing concentrations of
cycloheximide in cultures of B-CLL cells (*-*) and of normal












Figure 3 Time-course of the percentage of apoptosis induced in
cultures of B-CLL cells by various concentrations of cyclohex-
imide: no cycloheximide (* *); 10-7 M (A-A); 10-5 M
(- *); 10-3 M (--*).
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Figure 4 Agarose gel electrophoresis of DNA extracted from
cultured B-CLL cells. Lane 1, HindIII-digest of lambda phage
DNA serving as molecular weight marker; Lane 2, control, un-
treated B-CLL cells at 0 h; Lane 3, control cells, 6 h; Lane 4,
control cells, 24 h; Lanes 5 to 9, cells harvested after 24 h culture
with cycloheximide at concentrations of 10-2M; 1-0M; 10-4M;
10- M and 10-6 M respectively.
treated with lower concentrations (Figure 4). Untreated B-
CLL cells cultured for 24 h exhibited the least amount of
DNA fragmentation, whilst DNA from B-CLL cells harvest-
ed at the beginning of the experiments was completely un-
fragmented. The increasing amount of DNA fragmentation
with rising CHM concentration thus correlated with the in-
creasing percentage of morphologically recognisable apop-
tosis, indicating a strong dose relationship between the extent
of apoptosis and the activity of CHM.
Effect ofCHM on protein synthesis in normal tymphocytes
The effects of various concentrations of CHM on protein
synthesis in normal lymphocytes as determined by 35S
methionine corporation are shown in Table II. At a concen-
tration of 10- M, there was 78% inhibition of synthesis at
24 h, but only slight induction of apoptosis. At 10- M
inhibition was very marked, 95%, but apoptosis was exten-
sive. The results are the mean of five experiments.
Discussion
CHM did not inhibit the spontaneous apoptosis of B-CLL
cells that has been shown previously to follow their culture.
Indeed, treatment with CHM augmented apoptosis of these
cells in a dose-dependent manner and also resulted in apop-
tosis of cultured normal peripheral blood lymphocytes, albeit
to a lesser extent. Measurement of protein synthesis in the
latter cells showed that inhibition of synthesis by CHM was
also dose-dependent, and that at a concentration of the drug
that grossly depressed protein synthesis, apoptosis was exten-
sive.
Why CHM should inhibit apoptosis in some experimental
systems and not others is at present unknown. Theoretically,
protein synthesis might be required for the initiation of apop-
tosis by certain stimuli, for execution of the process or for
both of these. Involvement of protein synthesis in initiation
of the spontaneous apoptosis that follows culture of B-CLL
cells is not excluded by our experiments, since it was impossi-
ble to distinguish between apoptosis that might be occurring
spontaneously and that induced by CHM in the treated
cultures. The results clearly show, however, that extensive
apoptosis of B-CLL cells can proceed in the presence of
CHM at concentrations that have been reported to inhibit
the process in other systems.
The mechanisms involved in the induction of apoptosis of
B-CLL cells, of normal lymphocytes and of other cell types
by CHM (Searle et al., 1975; Martin et al., 1990; Waring,
1990; Takano et al., 1991) are uncertain. As well as inhibiting
protein synthesis by blocking peptidyl transferase activity of
the 60S ribosomal subunit (Stryer, 1988), CHM has diverse
effects on cell metabolism (discussed in Lee & Dewey, 1986).
Of particular possible relevance in the current context are its
ability to inhibit DNA synthesis (Hodge et al., 1969) and to
stimulate gene transcription by decreasing the concentration
of repressor (Elder et al., 1984; Forsdyke, 1984; Ishihara et
al., 1984; Makino et al., 1984). A number of cytotoxic anti-
biotics have been shown to bind to chromatin, causing con-
formational changes in DNA structure (reviewed in Portugal
& Waring, 1987). For example, Act D, frequently used to
study the dependence of apoptosis on mRNA and therefore
protein synthesis, causes the double helix to partially untwist
and become rigid (McGilvery, 1979). This latter effect may
result in exposure of the linker regions between nucleosomes
to the activity of endogenous endonuclease, thus producing
both the irreversible DNA fragmentation (Paier & Mak,
1974) and apoptosis known to follow exposure of some cell
types to Act D (Searle et al., 1975; Martin et al., 1990;
Waring, 1990). It is possible that a similar phenomenon is
occurring following treatment with CHM. The direct effects
of CHM on DNA clearly merit study. There are, never-
theless, alternative possibilities. It has been suggested by
some that certain cells are programmed to undergo apoptosis
in the absence of suppressor proteins, which are required to
be continually synthesised to maintain cell viability (Martin
et al., 1990; Waring, 1990). It has also been argued teleo-
logically that DNA damage by genotoxic agents may activate
a cellular self-destruct mechanism in the interest of the
animal as a whole (Wyllie et al., 1980; Cohen et al., 1985;
Sellins & Cohen, 1987).
The cause of the gross difference betwen B-CLL cells and
normal lymphocytes with respect to the concentration of
Table II Incorporation of35Smethionine (expressed ascountsperminute) andpercentageapoptosisat24 hin
samples of normal lymphocytes incubated with various concentrations ofcycloheximide
% Apoptosis
5min 2h 6h 21 h 24h at 24h
Untreated 1069 (305) 4592 (998) 13712 (5226) 35152 (9618) 50950 (10751) 1.7 (1.0)
CHM 10-5 M 1107 (360) 2866 (690) 3248 (865) 10378 (6757) 11367 (7299) 7.7 (2.9)
CHM 10-4 M 988 (341) 2371 (748) 3135 (1379) 4707 (543) 4043 (1290) 8.2 (1.5)
CHM 10-3M 710 (358) 2175 (901) 2367 (1203) 2679 (512) 2650(1124) 36.6 (10.0)
Standard deviations are given in brackets.522 R.J. COLLINS et al.
CHM required to enhance apoptosis is unknown, but may be
of relevance to tumour chemotherapy. Such variation in
susceptibility of different cell types to the apoptosis-inducing
effects of CHM may account for the failure of some authors
to observe enhancement ofapoptosis by this drug in the past.
It is noteworthy that, in the report of inhibition by CHM of
apoptosis of cultured endothelial cells induced by withdrawal
of fibroblast growth factor referred to in the introduction,
high concentrations of CHM were said to be 'cytotoxic'
(Araki et al., 1990). Our results emphasise that caution is
needed in drawing conclusions about a requirement for pro-
tein synthesis in apoptosis from experiments using a restrict-
ed range of concentrations of CHM. Possible multiple effects
of the drug need to be considered.
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